{"entity":{"type":"insider","cik":"0001831942","url":"/insider/0001831942","json_url":"/insider/0001831942.json","name":"COMMODORE CAPITAL LP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":25,"n_filings":17,"first":"2021-10-19","last":"2024-01-12","span_basis":"filed_date"},"name_variants":[{"name":"COMMODORE CAPITAL LP","source":"filing","n_filings":17,"first_seen":"2021-10-19","last_seen":"2024-01-12"}],"transactions":[{"id":2316261,"accession":"0001493152-24-002290","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-24-002290","line_url":"/filing/0001493152-24-002290#line-1","is_derivative":false,"issuer_cik":"0001831828","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001831828","owner_cik":"0001831942","owner_name":"COMMODORE CAPITAL LP","owner_display_name":"COMMODORE CAPITAL LP","owner_url":"/insider/0001831942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1050000.0,"shares_display":"1,050,000","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":18900000.0,"total_display":"18,900,000.00","total_whole":"18,900,000","shares_owned_after":4400000.0,"shares_owned_after_display":"4,400,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-01-10","filed_date":"2024-01-12","scope":"insider"},{"id":8497058,"accession":"0001493152-23-027352","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-23-027352","line_url":"/filing/0001493152-23-027352#line-1","is_derivative":false,"issuer_cik":"0001411685","issuer_name":"Vistagen Therapeutics, Inc.","issuer_ticker":"VTGN","issuer_name_source":null,"issuer_url":"/issuer/0001411685","owner_cik":"0001831942","owner_name":"COMMODORE CAPITAL LP","owner_display_name":"COMMODORE CAPITAL LP","owner_url":"/insider/0001831942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":775756.0,"shares_display":"775,756","price_per_share":23.153,"price_display":"23.15","price_state":"stated","total_value":17961078.668,"total_display":"17,961,078.67","total_whole":"17,961,079","shares_owned_after":1575000.0,"shares_owned_after_display":"1,575,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-07","filed_date":"2023-08-09","scope":"insider"},{"id":7932052,"accession":"0001493152-23-022130","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-23-022130","line_url":"/filing/0001493152-23-022130#line-1","is_derivative":false,"issuer_cik":"0001831828","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001831828","owner_cik":"0001831942","owner_name":"COMMODORE CAPITAL LP","owner_display_name":"COMMODORE CAPITAL LP","owner_url":"/insider/0001831942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":448217.0,"shares_display":"448,217","price_per_share":15.169,"price_display":"15.17","price_state":"stated","total_value":6799003.673,"total_display":"6,799,003.67","total_whole":"6,799,004","shares_owned_after":5450000.0,"shares_owned_after_display":"5,450,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-20","filed_date":"2023-06-22","scope":"insider"},{"id":8482394,"accession":"0001493152-23-006118","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-23-006118","line_url":"/filing/0001493152-23-006118#line-2","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"Enliven Therapeutics, Inc.","issuer_ticker":"ELVN","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001831942","owner_name":"COMMODORE CAPITAL LP","owner_display_name":"COMMODORE CAPITAL LP","owner_url":"/insider/0001831942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":621.75,"shares_display":"621.75","price_per_share":22.072,"price_display":"22.07","price_state":"stated","total_value":13723.266,"total_display":"13,723.27","total_whole":"13,723","shares_owned_after":718749.0,"shares_owned_after_display":"718,749","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-02-23","filed_date":"2023-02-27","scope":"insider"},{"id":8734246,"accession":"0001493152-23-005870","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001493152-23-005870","line_url":"/filing/0001493152-23-005870#line-2","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"IMARA Inc.","issuer_ticker":"IMRA","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001831942","owner_name":"COMMODORE CAPITAL LP","owner_display_name":"COMMODORE CAPITAL LP","owner_url":"/insider/0001831942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":23565.0,"shares_display":"23,565","price_per_share":5.113,"price_display":"5.11","price_state":"stated","total_value":120487.845,"total_display":"120,487.84","total_whole":"120,488","shares_owned_after":2872513.0,"shares_owned_after_display":"2,872,513","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-02-22","filed_date":"2023-02-23","scope":"insider"},{"id":8734243,"accession":"0001493152-23-005870","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-23-005870","line_url":"/filing/0001493152-23-005870#line-1","is_derivative":false,"issuer_cik":"0001672619","issuer_name":"IMARA Inc.","issuer_ticker":"IMRA","issuer_name_source":null,"issuer_url":"/issuer/0001672619","owner_cik":"0001831942","owner_name":"COMMODORE CAPITAL LP","owner_display_name":"COMMODORE CAPITAL LP","owner_url":"/insider/0001831942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8194.0,"shares_display":"8,194","price_per_share":5.249,"price_display":"5.25","price_state":"stated","total_value":43010.306,"total_display":"43,010.31","total_whole":"43,010","shares_owned_after":2848948.0,"shares_owned_after_display":"2,848,948","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-02-21","filed_date":"2023-02-23","scope":"insider"},{"id":6392115,"accession":"0001493152-22-032622","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-22-032622","line_url":"/filing/0001493152-22-032622#line-1","is_derivative":false,"issuer_cik":"0001692830","issuer_name":"Satsuma Pharmaceuticals, Inc.","issuer_ticker":"STSA","issuer_name_source":null,"issuer_url":"/issuer/0001692830","owner_cik":"0001831942","owner_name":"COMMODORE CAPITAL LP","owner_display_name":"COMMODORE CAPITAL LP","owner_url":"/insider/0001831942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.0001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3250000.0,"shares_display":"3,250,000","price_per_share":0.706,"price_display":"0.71","price_state":"stated","total_value":2294500.0,"total_display":"2,294,500.00","total_whole":"2,294,500","shares_owned_after":461286.0,"shares_owned_after_display":"461,286","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-14","filed_date":"2022-11-16","scope":"insider"},{"id":5134862,"accession":"0000905718-21-001545","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-21-001545","line_url":"/filing/0000905718-21-001545#line-1","is_derivative":false,"issuer_cik":"0001692830","issuer_name":"Satsuma Pharmaceuticals, Inc.","issuer_ticker":"STSA","issuer_name_source":null,"issuer_url":"/issuer/0001692830","owner_cik":"0001831942","owner_name":"COMMODORE CAPITAL LP","owner_display_name":"COMMODORE CAPITAL LP","owner_url":"/insider/0001831942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2922.0,"shares_display":"2,922","price_per_share":5.42,"price_display":"5.42","price_state":"stated","total_value":15837.24,"total_display":"15,837.24","total_whole":"15,837","shares_owned_after":3711286.0,"shares_owned_after_display":"3,711,286","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-24","filed_date":"2021-11-29","scope":"insider"},{"id":4710461,"accession":"0000905718-21-001523","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905718-21-001523","line_url":"/filing/0000905718-21-001523#line-2","is_derivative":false,"issuer_cik":"0001692830","issuer_name":"Satsuma Pharmaceuticals, Inc.","issuer_ticker":"STSA","issuer_name_source":null,"issuer_url":"/issuer/0001692830","owner_cik":"0001831942","owner_name":"COMMODORE CAPITAL LP","owner_display_name":"COMMODORE CAPITAL LP","owner_url":"/insider/0001831942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9979.0,"shares_display":"9,979","price_per_share":5.49,"price_display":"5.49","price_state":"stated","total_value":54784.71,"total_display":"54,784.71","total_whole":"54,785","shares_owned_after":3708364.0,"shares_owned_after_display":"3,708,364","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-22","filed_date":"2021-11-23","scope":"insider"},{"id":4710457,"accession":"0000905718-21-001523","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-21-001523","line_url":"/filing/0000905718-21-001523#line-1","is_derivative":false,"issuer_cik":"0001692830","issuer_name":"Satsuma Pharmaceuticals, Inc.","issuer_ticker":"STSA","issuer_name_source":null,"issuer_url":"/issuer/0001692830","owner_cik":"0001831942","owner_name":"COMMODORE CAPITAL LP","owner_display_name":"COMMODORE CAPITAL LP","owner_url":"/insider/0001831942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3225.0,"shares_display":"3,225","price_per_share":5.44,"price_display":"5.44","price_state":"stated","total_value":17544.0,"total_display":"17,544.00","total_whole":"17,544","shares_owned_after":3698385.0,"shares_owned_after_display":"3,698,385","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-19","filed_date":"2021-11-23","scope":"insider"},{"id":5088182,"accession":"0000905718-21-001471","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905718-21-001471","line_url":"/filing/0000905718-21-001471#line-2","is_derivative":false,"issuer_cik":"0001692830","issuer_name":"Satsuma Pharmaceuticals, Inc.","issuer_ticker":"STSA","issuer_name_source":null,"issuer_url":"/issuer/0001692830","owner_cik":"0001831942","owner_name":"COMMODORE CAPITAL LP","owner_display_name":"COMMODORE CAPITAL LP","owner_url":"/insider/0001831942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7941.0,"shares_display":"7,941","price_per_share":6.05,"price_display":"6.05","price_state":"stated","total_value":48043.05,"total_display":"48,043.05","total_whole":"48,043","shares_owned_after":3695160.0,"shares_owned_after_display":"3,695,160","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-11","filed_date":"2021-11-12","scope":"insider"},{"id":5088181,"accession":"0000905718-21-001471","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-21-001471","line_url":"/filing/0000905718-21-001471#line-1","is_derivative":false,"issuer_cik":"0001692830","issuer_name":"Satsuma Pharmaceuticals, Inc.","issuer_ticker":"STSA","issuer_name_source":null,"issuer_url":"/issuer/0001692830","owner_cik":"0001831942","owner_name":"COMMODORE CAPITAL LP","owner_display_name":"COMMODORE CAPITAL LP","owner_url":"/insider/0001831942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9622.0,"shares_display":"9,622","price_per_share":5.85,"price_display":"5.85","price_state":"stated","total_value":56288.7,"total_display":"56,288.70","total_whole":"56,289","shares_owned_after":3687219.0,"shares_owned_after_display":"3,687,219","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-10","filed_date":"2021-11-12","scope":"insider"},{"id":4088961,"accession":"0000905718-21-001460","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-21-001460","line_url":"/filing/0000905718-21-001460#line-1","is_derivative":false,"issuer_cik":"0001692830","issuer_name":"Satsuma Pharmaceuticals, Inc.","issuer_ticker":"STSA","issuer_name_source":null,"issuer_url":"/issuer/0001692830","owner_cik":"0001831942","owner_name":"COMMODORE CAPITAL LP","owner_display_name":"COMMODORE CAPITAL LP","owner_url":"/insider/0001831942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":560.0,"shares_display":"560","price_per_share":5.99,"price_display":"5.99","price_state":"stated","total_value":3354.4,"total_display":"3,354.40","total_whole":"3,354","shares_owned_after":3677597.0,"shares_owned_after_display":"3,677,597","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-08","filed_date":"2021-11-10","scope":"insider"},{"id":4307783,"accession":"0000905718-21-001450","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905718-21-001450","line_url":"/filing/0000905718-21-001450#line-2","is_derivative":false,"issuer_cik":"0001692830","issuer_name":"Satsuma Pharmaceuticals, Inc.","issuer_ticker":"STSA","issuer_name_source":null,"issuer_url":"/issuer/0001692830","owner_cik":"0001831942","owner_name":"COMMODORE CAPITAL LP","owner_display_name":"COMMODORE CAPITAL LP","owner_url":"/insider/0001831942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7800.0,"shares_display":"7,800","price_per_share":5.95,"price_display":"5.95","price_state":"stated","total_value":46410.0,"total_display":"46,410.00","total_whole":"46,410","shares_owned_after":3677037.0,"shares_owned_after_display":"3,677,037","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-05","filed_date":"2021-11-08","scope":"insider"},{"id":4307779,"accession":"0000905718-21-001450","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-21-001450","line_url":"/filing/0000905718-21-001450#line-1","is_derivative":false,"issuer_cik":"0001692830","issuer_name":"Satsuma Pharmaceuticals, Inc.","issuer_ticker":"STSA","issuer_name_source":null,"issuer_url":"/issuer/0001692830","owner_cik":"0001831942","owner_name":"COMMODORE CAPITAL LP","owner_display_name":"COMMODORE CAPITAL LP","owner_url":"/insider/0001831942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1400.0,"shares_display":"1,400","price_per_share":5.88,"price_display":"5.88","price_state":"stated","total_value":8232.0,"total_display":"8,232.00","total_whole":"8,232","shares_owned_after":3669237.0,"shares_owned_after_display":"3,669,237","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-04","filed_date":"2021-11-08","scope":"insider"},{"id":4869829,"accession":"0000905718-21-001430","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-21-001430","line_url":"/filing/0000905718-21-001430#line-1","is_derivative":false,"issuer_cik":"0001692830","issuer_name":"Satsuma Pharmaceuticals, Inc.","issuer_ticker":"STSA","issuer_name_source":null,"issuer_url":"/issuer/0001692830","owner_cik":"0001831942","owner_name":"COMMODORE CAPITAL LP","owner_display_name":"COMMODORE CAPITAL LP","owner_url":"/insider/0001831942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8880.0,"shares_display":"8,880","price_per_share":5.64,"price_display":"5.64","price_state":"stated","total_value":50083.2,"total_display":"50,083.20","total_whole":"50,083","shares_owned_after":3667837.0,"shares_owned_after_display":"3,667,837","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-02","filed_date":"2021-11-04","scope":"insider"},{"id":4406949,"accession":"0000905718-21-001420","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-21-001420","line_url":"/filing/0000905718-21-001420#line-1","is_derivative":false,"issuer_cik":"0001692830","issuer_name":"Satsuma Pharmaceuticals, Inc.","issuer_ticker":"STSA","issuer_name_source":null,"issuer_url":"/issuer/0001692830","owner_cik":"0001831942","owner_name":"COMMODORE CAPITAL LP","owner_display_name":"COMMODORE CAPITAL LP","owner_url":"/insider/0001831942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":44651.0,"shares_display":"44,651","price_per_share":5.71,"price_display":"5.71","price_state":"stated","total_value":254957.21,"total_display":"254,957.21","total_whole":"254,957","shares_owned_after":3658957.0,"shares_owned_after_display":"3,658,957","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-29","filed_date":"2021-11-02","scope":"insider"},{"id":4510531,"accession":"0000905718-21-001408","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905718-21-001408","line_url":"/filing/0000905718-21-001408#line-2","is_derivative":false,"issuer_cik":"0001692830","issuer_name":"Satsuma Pharmaceuticals, Inc.","issuer_ticker":"STSA","issuer_name_source":null,"issuer_url":"/issuer/0001692830","owner_cik":"0001831942","owner_name":"COMMODORE CAPITAL LP","owner_display_name":"COMMODORE CAPITAL LP","owner_url":"/insider/0001831942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15082.0,"shares_display":"15,082","price_per_share":5.55,"price_display":"5.55","price_state":"stated","total_value":83705.1,"total_display":"83,705.10","total_whole":"83,705","shares_owned_after":3614306.0,"shares_owned_after_display":"3,614,306","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-28","filed_date":"2021-10-29","scope":"insider"},{"id":4510527,"accession":"0000905718-21-001408","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-21-001408","line_url":"/filing/0000905718-21-001408#line-1","is_derivative":false,"issuer_cik":"0001692830","issuer_name":"Satsuma Pharmaceuticals, Inc.","issuer_ticker":"STSA","issuer_name_source":null,"issuer_url":"/issuer/0001692830","owner_cik":"0001831942","owner_name":"COMMODORE CAPITAL LP","owner_display_name":"COMMODORE CAPITAL LP","owner_url":"/insider/0001831942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":39581.0,"shares_display":"39,581","price_per_share":5.45,"price_display":"5.45","price_state":"stated","total_value":215716.45,"total_display":"215,716.45","total_whole":"215,716","shares_owned_after":3599224.0,"shares_owned_after_display":"3,599,224","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-27","filed_date":"2021-10-29","scope":"insider"},{"id":5329400,"accession":"0000905718-21-001391","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905718-21-001391","line_url":"/filing/0000905718-21-001391#line-2","is_derivative":false,"issuer_cik":"0001692830","issuer_name":"Satsuma Pharmaceuticals, Inc.","issuer_ticker":"STSA","issuer_name_source":null,"issuer_url":"/issuer/0001692830","owner_cik":"0001831942","owner_name":"COMMODORE CAPITAL LP","owner_display_name":"COMMODORE CAPITAL LP","owner_url":"/insider/0001831942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":27629.0,"shares_display":"27,629","price_per_share":5.51,"price_display":"5.51","price_state":"stated","total_value":152235.79,"total_display":"152,235.79","total_whole":"152,236","shares_owned_after":3559643.0,"shares_owned_after_display":"3,559,643","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-22","filed_date":"2021-10-25","scope":"insider"},{"id":5329396,"accession":"0000905718-21-001391","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-21-001391","line_url":"/filing/0000905718-21-001391#line-1","is_derivative":false,"issuer_cik":"0001692830","issuer_name":"Satsuma Pharmaceuticals, Inc.","issuer_ticker":"STSA","issuer_name_source":null,"issuer_url":"/issuer/0001692830","owner_cik":"0001831942","owner_name":"COMMODORE CAPITAL LP","owner_display_name":"COMMODORE CAPITAL LP","owner_url":"/insider/0001831942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":32816.0,"shares_display":"32,816","price_per_share":5.4,"price_display":"5.40","price_state":"stated","total_value":177206.4,"total_display":"177,206.40","total_whole":"177,206","shares_owned_after":3532014.0,"shares_owned_after_display":"3,532,014","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-21","filed_date":"2021-10-25","scope":"insider"},{"id":4930688,"accession":"0000905718-21-001384","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905718-21-001384","line_url":"/filing/0000905718-21-001384#line-2","is_derivative":false,"issuer_cik":"0001692830","issuer_name":"Satsuma Pharmaceuticals, Inc.","issuer_ticker":"STSA","issuer_name_source":null,"issuer_url":"/issuer/0001692830","owner_cik":"0001831942","owner_name":"COMMODORE CAPITAL LP","owner_display_name":"COMMODORE CAPITAL LP","owner_url":"/insider/0001831942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40663.0,"shares_display":"40,663","price_per_share":5.44,"price_display":"5.44","price_state":"stated","total_value":221206.72,"total_display":"221,206.72","total_whole":"221,207","shares_owned_after":3499198.0,"shares_owned_after_display":"3,499,198","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-20","filed_date":"2021-10-21","scope":"insider"},{"id":4930683,"accession":"0000905718-21-001384","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-21-001384","line_url":"/filing/0000905718-21-001384#line-1","is_derivative":false,"issuer_cik":"0001692830","issuer_name":"Satsuma Pharmaceuticals, Inc.","issuer_ticker":"STSA","issuer_name_source":null,"issuer_url":"/issuer/0001692830","owner_cik":"0001831942","owner_name":"COMMODORE CAPITAL LP","owner_display_name":"COMMODORE CAPITAL LP","owner_url":"/insider/0001831942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":87580.0,"shares_display":"87,580","price_per_share":5.07,"price_display":"5.07","price_state":"stated","total_value":444030.6,"total_display":"444,030.60","total_whole":"444,031","shares_owned_after":3458535.0,"shares_owned_after_display":"3,458,535","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-19","filed_date":"2021-10-21","scope":"insider"},{"id":4977036,"accession":"0000905718-21-001373","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905718-21-001373","line_url":"/filing/0000905718-21-001373#line-2","is_derivative":false,"issuer_cik":"0001692830","issuer_name":"Satsuma Pharmaceuticals, Inc.","issuer_ticker":"STSA","issuer_name_source":null,"issuer_url":"/issuer/0001692830","owner_cik":"0001831942","owner_name":"COMMODORE CAPITAL LP","owner_display_name":"COMMODORE CAPITAL LP","owner_url":"/insider/0001831942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":36194.0,"shares_display":"36,194","price_per_share":4.87,"price_display":"4.87","price_state":"stated","total_value":176264.78,"total_display":"176,264.78","total_whole":"176,265","shares_owned_after":3370955.0,"shares_owned_after_display":"3,370,955","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-18","filed_date":"2021-10-19","scope":"insider"},{"id":4977031,"accession":"0000905718-21-001373","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-21-001373","line_url":"/filing/0000905718-21-001373#line-1","is_derivative":false,"issuer_cik":"0001692830","issuer_name":"Satsuma Pharmaceuticals, Inc.","issuer_ticker":"STSA","issuer_name_source":null,"issuer_url":"/issuer/0001692830","owner_cik":"0001831942","owner_name":"COMMODORE CAPITAL LP","owner_display_name":"COMMODORE CAPITAL LP","owner_url":"/insider/0001831942","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":126000.0,"shares_display":"126,000","price_per_share":4.83,"price_display":"4.83","price_state":"stated","total_value":608580.0,"total_display":"608,580.00","total_whole":"608,580","shares_owned_after":3334761.0,"shares_owned_after_display":"3,334,761","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-15","filed_date":"2021-10-19","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":25,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":23,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":25},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001831828","name":"Vera Therapeutics, Inc.","url":"/issuer/0001831828","role":"Ten percent owner","n_filings":2,"first_seen":"2023-06-22","last_seen":"2024-01-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001411685","name":"Vistagen Therapeutics, Inc.","url":"/issuer/0001411685","role":"Ten percent owner","n_filings":1,"first_seen":"2023-08-09","last_seen":"2023-08-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001672619","name":"Enliven Therapeutics, Inc.","url":"/issuer/0001672619","role":"Ten percent owner","n_filings":2,"first_seen":"2023-02-23","last_seen":"2023-02-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001692830","name":"Satsuma Pharmaceuticals, Inc.","url":"/issuer/0001692830","role":"Ten percent owner","n_filings":12,"first_seen":"2021-10-19","last_seen":"2022-11-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001831942","retrieved_at":"2026-08-26T20:22:11+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}